181 related articles for article (PubMed ID: 23543114)
21. Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes.
Mialet-Perez J; D'Angelo R; Villeneuve C; Ordener C; Nègre-Salvayre A; Parini A; Vindis C
J Mol Cell Cardiol; 2012 Feb; 52(2):502-10. PubMed ID: 21820441
[TBL] [Abstract][Full Text] [Related]
22. Cadherin-11-Interleukin-6 Signaling between Cardiac Fibroblast and Cardiomyocyte Promotes Ventricular Remodeling in a Mouse Pressure Overload-Induced Heart Failure Model.
Fang G; Li Y; Yuan J; Cao W; Song S; Chen L; Wang Y; Wang Q
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047522
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
24. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
25. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
26. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
27. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2.
Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J
Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094
[TBL] [Abstract][Full Text] [Related]
29. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
30. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
31. Distinct roles of calmodulin and Ca
Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L
Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334
[TBL] [Abstract][Full Text] [Related]
32. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
[TBL] [Abstract][Full Text] [Related]
33. Reduced cardiac fructose 2,6 bisphosphate increases hypertrophy and decreases glycolysis following aortic constriction.
Wang J; Xu J; Wang Q; Brainard RE; Watson LJ; Jones SP; Epstein PN
PLoS One; 2013; 8(1):e53951. PubMed ID: 23308291
[TBL] [Abstract][Full Text] [Related]
34. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.
Chen M; Xin J; Liu B; Luo L; Li J; Yin W; Li M
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473037
[TBL] [Abstract][Full Text] [Related]
36. Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy.
Harada M; Takeishi Y; Arimoto T; Niizeki T; Kitahara T; Goto K; Walsh RA; Kubota I
Circ J; 2007 Feb; 71(2):276-82. PubMed ID: 17251681
[TBL] [Abstract][Full Text] [Related]
37. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.
Patten RD; Pourati I; Aronovitz MJ; Alsheikh-Ali A; Eder S; Force T; Mendelsohn ME; Karas RH
J Card Fail; 2008 Apr; 14(3):245-53. PubMed ID: 18381189
[TBL] [Abstract][Full Text] [Related]
38. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice.
Omede A; Zi M; Prehar S; Maqsood A; Stafford N; Mamas M; Cartwright E; Oceandy D
Biochem Biophys Res Commun; 2016 Oct; 479(4):708-714. PubMed ID: 27693579
[TBL] [Abstract][Full Text] [Related]
39. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
[TBL] [Abstract][Full Text] [Related]
40. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
